‘No need to rush’: Senator warns of FDA’s shortcuts to full approval of COVID-19 vaccine

‘No need to rush’: Senator warns of FDA’s shortcuts to full approval of COVID-19 vaccine (Archived)

“I see no need to rush the FDA approval process for any of the three COVID-19 vaccines. Expediting the process appears to only serve the political purpose of imposing and enforcing vaccine mandates,” Mr. Johnson wrote in the letter, a copy of which was obtained by The Washington Times.

U.S. Surgeon General Vivek Murthy told “Fox News Sunday” that moving the Pfizer vaccine from “emergency” to “full approval” would make mandates more appealing.

Former FDA Commissioner Scott Gottlieb, who is on the Pfizer board of directors, also said the full approval will prompt more vaccine mandates.

Related:

Gottlieb’s Pfizer Announces $1.95 Billion Deal with Feds for COVID-19 Vaccine

Just hours before the Pfizer vaccine news became public, Gottlieb appeared on CNBC’s Squawk Box to explain that any vaccine will need to be administered on an annual basis.

Source.

Some more notes that I made, about Gottlieb and the coronavirus, in March 2020.

CDC study shows 74% of people infected in Massachusetts Covid outbreak were fully vaccinated

CDC study shows 74% of people infected in Massachusetts Covid outbreak were fully vaccinated

While the delta variant continues to hit unvaccinated people the hardest, some vaccinated people could be carrying higher levels of the virus than previously understood and are potentially transmitting it to others, Walensky told reporters on a call Tuesday. She added the variant behaves “uniquely differently from past strains of the virus.”

Related:

CDC Scaled Back Hunt for Breakthrough Cases Just as the Delta Variant Grew – Bloomberg identified more than 100,000 vaccine breakthroughs